(Q52477376)

English

Long-term prognostic value of serum beta 2 microglobulin in myelomatosis.

scientific article published in August 1990

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 May 2018

http://europepmc.org/abstract/MED/2119793

Long-term prognostic value of serum beta 2 microglobulin in myelomatosis. (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 May 2018

http://europepmc.org/abstract/MED/2119793

Bianca Lucia De Stavola

2

1 reference

Europe PubMed Central

PubMed publication ID

2 May 2018

http://europepmc.org/abstract/MED/2119793

author name string

Cuzick J

1

1 reference

Europe PubMed Central

PubMed publication ID

2 May 2018

http://europepmc.org/abstract/MED/2119793

Cooper EH

3

1 reference

Europe PubMed Central

PubMed publication ID

2 May 2018

http://europepmc.org/abstract/MED/2119793

Chapman C

4

1 reference

Europe PubMed Central

PubMed publication ID

2 May 2018

http://europepmc.org/abstract/MED/2119793

MacLennan IC

5

1 reference

Europe PubMed Central

PubMed publication ID

2 May 2018

http://europepmc.org/abstract/MED/2119793

language of work or name

0 references

publication date

1 August 1990

1 reference

Europe PubMed Central

PubMed publication ID

2 May 2018

http://europepmc.org/abstract/MED/2119793

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

2 May 2018

http://europepmc.org/abstract/MED/2119793

75

1 reference

Europe PubMed Central

PubMed publication ID

2 May 2018

http://europepmc.org/abstract/MED/2119793

4

1 reference

Europe PubMed Central

PubMed publication ID

2 May 2018

http://europepmc.org/abstract/MED/2119793

506-510

1 reference

Europe PubMed Central

PubMed publication ID

2 May 2018

http://europepmc.org/abstract/MED/2119793

Evaluation of serum β 2-microglobulin as a prognostic indicator in myelomatosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1990.TB07790.X

21 January 2018

The prognostic value of serum beta 2 microglobulin compared with other presentation features in myelomatosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1990.TB07790.X

21 January 2018

Serum β 2-microglobulin in myelomatosis: potential value in stratification and monitoring

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1990.TB07790.X

21 January 2018

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1990.TB07790.X

21 January 2018

Identifiers

10.1111/J.1365-2141.1990.TB07790.X

1 reference

Europe PubMed Central

PubMed publication ID

2 May 2018

http://europepmc.org/abstract/MED/2119793

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 May 2018

http://europepmc.org/abstract/MED/2119793

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52477376&oldid=1107996040"